All lobbying filings

THE MCMANUS GROUP

Lobbying for ROCHE DIAGNOSTICS · Diagnostic test manufacturing

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $40,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

HR 5269
RESULTS Act
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 1

Medicare/Medicaid

H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.